• Je něco špatně v tomto záznamu ?

Long-QT founder variant T309I-Kv7.1 with dominant negative pattern may predispose delayed afterdepolarizations under β-adrenergic stimulation

I. Synková, M. Bébarová, I. Andršová, L. Chmelikova, O. Švecová, J. Hošek, M. Pásek, P. Vít, I. Valášková, R. Gaillyová, R. Navrátil, T. Novotný

. 2021 ; 11 (1) : 3573. [pub] 20210211

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc22004618

Grantová podpora
NV16-30571A MZ0 CEP - Centrální evidence projektů

The variant c.926C > T (p.T309I) in KCNQ1 gene was identified in 10 putatively unrelated Czech families with long QT syndrome (LQTS). Mutation carriers (24 heterozygous individuals) were more symptomatic compared to their non-affected relatives (17 individuals). The carriers showed a mild LQTS phenotype including a longer QTc interval at rest (466 ± 24 ms vs. 418 ± 20 ms) and after exercise (508 ± 32 ms vs. 417 ± 24 ms), 4 syncopes and 2 aborted cardiac arrests. The same haplotype associated with the c.926C > T variant was identified in all probands. Using the whole cell patch clamp technique and confocal microscopy, a complete loss of channel function was revealed in the homozygous setting, caused by an impaired channel trafficking. Dominant negativity with preserved reactivity to β-adrenergic stimulation was apparent in the heterozygous setting. In simulations on a human ventricular cell model, the dysfunction resulted in delayed afterdepolarizations (DADs) and premature action potentials under β-adrenergic stimulation that could be prevented by a slight inhibition of calcium current. We conclude that the KCNQ1 variant c.926C > T is the first identified LQTS-related founder mutation in Central Europe. The dominant negative channel dysfunction may lead to DADs under β-adrenergic stimulation. Inhibition of calcium current could be possible therapeutic strategy in LQTS1 patients refractory to β-blocker therapy.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22004618
003      
CZ-PrNML
005      
20230518101128.0
007      
ta
008      
220113s2021 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s41598-021-81670-1 $2 doi
035    __
$a (PubMed)33574382
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Synková, Iva $u Department of Medical Genetics, University Hospital Brno and Faculty of Medicine, Masaryk University, Jihlavská 20, 625 00, Brno, Czech Republic $u Department of Experimental Biology, Faculty of Science, Masaryk University, Kotlářská 267/2, 611 37, Brno, Czech Republic
245    10
$a Long-QT founder variant T309I-Kv7.1 with dominant negative pattern may predispose delayed afterdepolarizations under β-adrenergic stimulation / $c I. Synková, M. Bébarová, I. Andršová, L. Chmelikova, O. Švecová, J. Hošek, M. Pásek, P. Vít, I. Valášková, R. Gaillyová, R. Navrátil, T. Novotný
520    9_
$a The variant c.926C > T (p.T309I) in KCNQ1 gene was identified in 10 putatively unrelated Czech families with long QT syndrome (LQTS). Mutation carriers (24 heterozygous individuals) were more symptomatic compared to their non-affected relatives (17 individuals). The carriers showed a mild LQTS phenotype including a longer QTc interval at rest (466 ± 24 ms vs. 418 ± 20 ms) and after exercise (508 ± 32 ms vs. 417 ± 24 ms), 4 syncopes and 2 aborted cardiac arrests. The same haplotype associated with the c.926C > T variant was identified in all probands. Using the whole cell patch clamp technique and confocal microscopy, a complete loss of channel function was revealed in the homozygous setting, caused by an impaired channel trafficking. Dominant negativity with preserved reactivity to β-adrenergic stimulation was apparent in the heterozygous setting. In simulations on a human ventricular cell model, the dysfunction resulted in delayed afterdepolarizations (DADs) and premature action potentials under β-adrenergic stimulation that could be prevented by a slight inhibition of calcium current. We conclude that the KCNQ1 variant c.926C > T is the first identified LQTS-related founder mutation in Central Europe. The dominant negative channel dysfunction may lead to DADs under β-adrenergic stimulation. Inhibition of calcium current could be possible therapeutic strategy in LQTS1 patients refractory to β-blocker therapy.
650    _2
$a beta blokátory $x aplikace a dávkování $x škodlivé účinky $7 D000319
650    _2
$a dospělí $7 D000328
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a genetické asociační studie $7 D056726
650    _2
$a detekce genetických nosičů $7 D006580
650    12
$a genetická predispozice k nemoci $7 D020022
650    _2
$a genotyp $7 D005838
650    _2
$a haplotypy $x genetika $7 D006239
650    _2
$a heterozygot $7 D006579
650    _2
$a homozygot $7 D006720
650    _2
$a lidé $7 D006801
650    _2
$a draslíkový kanál KCNQ1 $x genetika $7 D051657
650    _2
$a syndrom dlouhého QT $x genetika $x patologie $7 D008133
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a mutace $x genetika $7 D009154
650    _2
$a rodokmen $7 D010375
650    _2
$a fenotyp $7 D010641
651    _2
$a Evropa $7 D005060
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Bébarová, Markéta $u Department of Physiology, Faculty of Medicine, Masaryk University, Kamenice 5, 625 00, Brno, Czech Republic. mbebar@med.muni.cz
700    1_
$a Andršová, Irena $u Department of Internal Medicine and Cardiology, University Hospital Brno and Faculty of Medicine, Masaryk University, Jihlavská 20, 625 00, Brno, Czech Republic
700    1_
$a Chmelikova, Larisa $u Department of Biomedical Engineering, Faculty of Electrical Engineering and Communication, Brno University of Technology, Technická 10, 616 00, Brno, Czech Republic
700    1_
$a Švecová, Olga $u Department of Physiology, Faculty of Medicine, Masaryk University, Kamenice 5, 625 00, Brno, Czech Republic $7 xx0301708
700    1_
$a Hošek, Jan $u Division of Biologically Active Complexes and Molecular Magnets, Regional Centre of Advanced Technologies and Materials, Faculty of Science, Palacký University in Olomouc, Šlechtitelů 27, 783 71, Olomouc, Czech Republic
700    1_
$a Pásek, Michal $u Department of Physiology, Faculty of Medicine, Masaryk University, Kamenice 5, 625 00, Brno, Czech Republic $u Institute of Thermomechanics, Czech Academy of Sciences, Dolejškova 5, 182 00, Prague, Czech Republic
700    1_
$a Vít, Pavel $u Department of Paediatrics, University Hospital Brno and Faculty of Medicine, Masaryk University, Černopolní 9, 613 00, Brno, Czech Republic
700    1_
$a Valášková, Iveta $u Department of Medical Genetics, University Hospital Brno and Faculty of Medicine, Masaryk University, Jihlavská 20, 625 00, Brno, Czech Republic
700    1_
$a Gaillyová, Renata $u Department of Medical Genetics, University Hospital Brno and Faculty of Medicine, Masaryk University, Jihlavská 20, 625 00, Brno, Czech Republic
700    1_
$a Navrátil, Rostislav $u Repromeda, Clinic for Reproductive Medicine and Preimplantation Genetic Diagnosis, Biology Park, Studentská 812/6, 625 00, Brno, Czech Republic
700    1_
$a Novotný, Tomáš $u Department of Internal Medicine and Cardiology, University Hospital Brno and Faculty of Medicine, Masaryk University, Jihlavská 20, 625 00, Brno, Czech Republic
773    0_
$w MED00182195 $t Scientific reports $x 2045-2322 $g Roč. 11, č. 1 (2021), s. 3573
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33574382 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220113 $b ABA008
991    __
$a 20230518101123 $b ABA008
999    __
$a ok $b bmc $g 1751930 $s 1155767
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 11 $c 1 $d 3573 $e 20210211 $i 2045-2322 $m Scientific reports $n Sci Rep $x MED00182195
GRA    __
$a NV16-30571A $p MZ0
LZP    __
$a Pubmed-20220113

Najít záznam

Citační ukazatele

Možnosti archivace